McGuire A, et al. Effects of age on the detection and management of breast cancer. Cancers. 2015;7(2):908–29.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen L, et al. Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage. Breast Cancer Res Treat. 2014;147(3):609–16.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
Article
PubMed
Google Scholar
Hodi FS, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nanda R, et al. Pembrolizumab in patients with advanced triple-negative breast Cancer: phase Ib KEYNOTE-012 study. J Clin Oncol. 2016;34(21):2460–7.
Article
CAS
PubMed
Google Scholar
Polk A, et al. Checkpoint inhibitors in breast cancer - current status. Cancer Treat Rev. 2017;63:122–34.
Article
PubMed
Google Scholar
Rugo HS, et al. Abstract S5-07: preliminary efficacy and safety of pembrolizumab (MK-3475) in patients with PD-L1–positive, estrogen receptor-positive (ER+)/HER2-negative advanced breast cancer enrolled in KEYNOTE-028. Cancer Res. 2016;76(4 Supplement):S5–07.
Google Scholar
Sylvia A, et al. Phase Ib trial of atezolizumab in combination with nab-paclitaxel in patients with metastatic triple-negative breast cancer (mTNBC). J Clin Oncol. 2016;34(15_suppl):1009.
Article
Google Scholar
Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell. 2000;101(5):455–8.
Article
CAS
PubMed
Google Scholar
Lim HW, et al. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol. 2005;175(7):4180–3.
Article
CAS
PubMed
Google Scholar
Trzonkowski P, et al. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction. Clin Immunol. 2004;112(3):258–67.
Article
CAS
PubMed
Google Scholar
Betts GJ, et al. Regulating the immune response to tumours. Adv Drug Deliv Rev. 2006;58(8):948–61.
Article
CAS
PubMed
Google Scholar
Fu J, et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology. 2007;132(7):2328–39.
Article
PubMed
Google Scholar
Sasada T, et al. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer. 2003;98(5):1089–99.
Article
PubMed
Google Scholar
Denkert C, et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol. 2010;28(1):105–13.
Article
CAS
Google Scholar
Issa-Nummer Y, et al. Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial. PLoS One. 2013;8(12):e79775.
Article
PubMed
PubMed Central
Google Scholar
Mahmoud SM, et al. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol. 2011;29(15):1949–55.
Article
PubMed
Google Scholar
Bense RD, et al. Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer. J Natl Cancer Inst. 2017;109:1.
Article
Google Scholar
Shou J, et al. Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysis. BMC Cancer. 2016;16:687.
Article
PubMed
PubMed Central
Google Scholar
Wang Y, et al. Regulatory T cells are an important prognostic factor in breast cancer: a systematic review and meta-analysis. Neoplasma. 2016;63(5):789–98.
Article
CAS
PubMed
Google Scholar
Curiel TJ, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10(9):942–9.
Article
CAS
PubMed
Google Scholar
Maruyama T, et al. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma. Dis Esophagus. 2010;23(5):422–9.
CAS
PubMed
Google Scholar
Mizukami Y, et al. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer. Int J Cancer. 2008;122(10):2286–93.
Article
CAS
PubMed
Google Scholar
Wagsater D, et al. Quantification of the chemokines CCL17 and CCL22 in human colorectal adenocarcinomas. Mol Med Rep. 2008;1(2):211–7.
PubMed
Google Scholar
Gobert M, et al. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 2009;69(5):2000–9.
Barsheshet Y, et al. CCR8 (+) FOXp3(+) Treg cells as master drivers of immune regulation. Proc Natl Acad Sci U S A. 2017;114(23):6086–91.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xu Y, et al. Sox2 communicates with Tregs through CCL1 to promote the Stemness property of breast. Cancer Cells. 2017;35(12):2351–65.
CAS
Google Scholar
Freier, CP. Role of regulatory T cells and associated chemokines in human gynecological tumors. Dissertation, LMU München: Medizinische Fakultät. Munich, 2016.
Freier CP, et al. FOXP3+ cells recruited by CCL22 into breast Cancer correlates with less tumor nodal infiltration. Anticancer Res. 2016;36(6):3139–45.
CAS
PubMed
Google Scholar
Bates GJ, et al. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol. 2006;24(34):5373–80.
Article
PubMed
Google Scholar
Anz D, et al. In breast cancer, a high ratio of tumour-infiltrating intraepithelial CD8+ to FoxP3+ cells is characteristic for the medullary subtype. Histopathology. 2011;59(5):965–74.
Article
PubMed
Google Scholar
Hoelzinger DB, et al. Blockade of CCL1 inhibits T regulatory cell suppressive function enhancing tumor immunity without affecting T effector responses. J Immunol. 2010;184(12):6833–42.
Article
CAS
PubMed
Google Scholar
Shang B, et al. Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci Rep. 2015;5:15179.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ghia P, et al. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22. Eur J Immunol. 2002;32(5):1403–13.
Article
CAS
PubMed
Google Scholar
Yang P, et al. TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell. 2012;22(3):291–303.
Article
CAS
PubMed
PubMed Central
Google Scholar
Facciabene A, et al. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T (reg) cells. Nature. 2011;475(7355):226–30.
Article
CAS
PubMed
Google Scholar
Tan MC, et al. Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol. 2009;182(3):1746–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen KJ, et al. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis. PLoS One. 2011;6(9):e24671.
Article
CAS
PubMed
PubMed Central
Google Scholar
Barsheshet Y, et al. CCR8+FOXp3+ Treg cells as master drivers of immune regulation. Proc Natl Acad Sci U S A. 2017;114(23):6086–91.
Article
CAS
PubMed
PubMed Central
Google Scholar
Palacios-Arreola MI, et al. The role of chemokines in breast cancer pathology and its possible use as therapeutic targets. J Immunol Res. 2014;2014:849720.
Article
PubMed
PubMed Central
Google Scholar
Ben-Baruch A. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev. 2006;25(3):357–71.
Article
CAS
PubMed
Google Scholar
Fujimoto H, et al. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. Int J Cancer. 2009;125(6):1276–84.
Article
CAS
PubMed
Google Scholar
Soria G, Ben-Baruch A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 2008;267(2):271–85.
Article
CAS
PubMed
Google Scholar
Ueno T, et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res. 2000;6(8):3282–9.
CAS
PubMed
Google Scholar
Faget J, et al. Early detection of tumor cells by innate immune cells leads to T (reg) recruitment through CCL22 production by tumor cells. Cancer Res. 2011;71(19):6143–52.
Article
CAS
PubMed
Google Scholar
Plitas G, et al. Regulatory T cells exhibit distinct features in human breast Cancer. Immunity. 2016;45(5):1122–34.
Article
CAS
PubMed
PubMed Central
Google Scholar